GB/T 40225-2021

Active

Determination of actin antibody—Western blotting method

肌动蛋白抗体的检测免疫印迹法

Standard Type

GBT

ICS

07.080

CCS

A40

Status

Active

Issue Date

2021-05-21

Implementation

2021-12-01

Centralized Committee

国家标准委

Issuing Authority

国家市场监督管理总局、中国国家标准化管理委员会

Application Summary AI generated

This standard specifies the Western blotting method for detecting actin antibodies in human serum or plasma. It is applied in clinical laboratories and medical testing facilities for the diagnosis and monitoring of autoimmune diseases, such as autoimmune hepatitis and systemic lupus erythematosus, where anti-actin antibodies serve as a biomarker. The standard ensures consistent and reliable testing procedures across different laboratories.

Related Standards

NY/T 702-2003 Hop NY 626-2002 Shennong synthetic line pig NY 624-2002 Jun Mu No. 1 white pig NY/T 629-2002 Propolis NY 625-2002 Composite line DEKALB breeding pig NY 623-2002 Inner Mongolia Cashmere Goat GB/Z 44313-2024 Biotechnology—Biobanking—Requirements for the biobanking of plant biological material for research and development GB/Z 44314-2024 Biotechnology—Biobanking—Requirements for the biobanking of animal biological material

Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.